OBJECTIVE: To describe the first clinical application of a novel tissue Doppler derived index of contractility, isovolumic acceleration (IVA), in the assessment of the ventricular myocardial force-frequency relation (FFR) in the univentricular heart (UVH). DESIGN: Prospective study. SETTING: Tertiary referral centre. INTERVENTIONS: Non-invasive assessment of the myocardial FFR by tissue Doppler echocardiography during atrial pacing. RESULTS: IVA was used to measure the FFR of the systemic ventricle in patients with structurally normal hearts and in patients with UVHs. Basal IVA of the normal hearts (mean (SD) 1.9 (0.3) m/s2) was significantly greater than that of UVHs in patients with a dominant right ventricle (RV) (1.0 (0.3) m/s2) or left ventricle (LV) (0.8 (0.7) m/s2; p < 0.05 for both). Neither the absolute nor percentage change from basal to peak values of IVA with pacing differed between the three groups. Peak force developed by the normal LV was significantly greater than that of the UVH, dominant LV group but not different from that of the UVH, dominant RV group. CONCLUSION: Contractility at basal heart rate is depressed in patients with UVH compared with the normal LV. Analysis of ventricular FFRs exposes further differences in myocardial contractility. There is no evidence that contractile function of the dominant RV is inferior to that of the dominant LV over a physiological range of heart rates.
OBJECTIVE: To describe the first clinical application of a novel tissue Doppler derived index of contractility, isovolumic acceleration (IVA), in the assessment of the ventricular myocardial force-frequency relation (FFR) in the univentricular heart (UVH). DESIGN: Prospective study. SETTING: Tertiary referral centre. INTERVENTIONS: Non-invasive assessment of the myocardial FFR by tissue Doppler echocardiography during atrial pacing. RESULTS:IVA was used to measure the FFR of the systemic ventricle in patients with structurally normal hearts and in patients with UVHs. Basal IVA of the normal hearts (mean (SD) 1.9 (0.3) m/s2) was significantly greater than that of UVHs in patients with a dominant right ventricle (RV) (1.0 (0.3) m/s2) or left ventricle (LV) (0.8 (0.7) m/s2; p < 0.05 for both). Neither the absolute nor percentage change from basal to peak values of IVA with pacing differed between the three groups. Peak force developed by the normal LV was significantly greater than that of the UVH, dominant LV group but not different from that of the UVH, dominant RV group. CONCLUSION: Contractility at basal heart rate is depressed in patients with UVH compared with the normal LV. Analysis of ventricular FFRs exposes further differences in myocardial contractility. There is no evidence that contractile function of the dominant RV is inferior to that of the dominant LV over a physiological range of heart rates.
Authors: J William Gaynor; Nancy D Bridges; Mitchell I Cohen; William T Mahle; William M Decampli; James M Steven; Susan C Nicolson; Thomas L Spray Journal: J Thorac Cardiovasc Surg Date: 2002-02 Impact factor: 5.209
Authors: J M Cotton; M T Kearney; P A MacCarthy; R M Grocott-Mason; D R McClean; C Heymes; P J Richardson; A M Shah Journal: Circulation Date: 2001-11-06 Impact factor: 29.690
Authors: Michael Vogel; Michael M H Cheung; Jia Li; Steen B Kristiansen; Michael R Schmidt; Paul A White; Keld Sorensen; Andrew N Redington Journal: Circulation Date: 2003-03-17 Impact factor: 29.690
Authors: Michael Vogel; Michael R Schmidt; Steen B Kristiansen; Michael Cheung; Paul A White; Keld Sorensen; Andrew N Redington Journal: Circulation Date: 2002-04-09 Impact factor: 29.690
Authors: Richard R Bouchard; Jeremy J Dahl; Stephen J Hsu; Mark L Palmeri; Gregg E Trahey Journal: IEEE Trans Ultrason Ferroelectr Freq Control Date: 2009-01 Impact factor: 2.725
Authors: Alexander Van De Bruaene; Lukas Meier; Walter Droogne; Pieter De Meester; Els Troost; Marc Gewillig; Werner Budts Journal: Heart Fail Rev Date: 2018-01 Impact factor: 4.214
Authors: M R Schmidt; P A White; S Khambadkone; G J Gross; H E Bøtker; M Vogel; V E Hjortdal; K E Sørensen; A N Redington Journal: Pediatr Cardiol Date: 2011-03-11 Impact factor: 1.655